Explore
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
Read More
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with Revenue Growth
Read More
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth
Read More
Trendline
AtriCure Reports Significant Revenue Growth in First Quarter 2026
AtriCure Reports Significant Revenue Growth in First Quarter 2026
Read More
Trendline
Penumbra, Inc. Reports Strong First Quarter 2026 Financial Results Amid Pending Acquisition
Penumbra, Inc. Reports Strong First Quarter 2026 Financial Results Amid Pending Acquisition
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Read More
Trendline
Remitly Reports Record Q1 2026 Results and Raises Full-Year Outlook
Remitly Reports Record Q1 2026 Results and Raises Full-Year Outlook
Read More
Trendline
Pulmonx Corp Reports Decline in Q1 2026 Revenue Amid China Shipment Delays
Pulmonx Corp Reports Decline in Q1 2026 Revenue Amid China Shipment Delays
Read More
Trendline
UL Solutions Inc. Reports Strong First Quarter 2026 Financial Results with Significant Margin Expansion
UL Solutions Inc. Reports Strong First Quarter 2026 Financial Results with Significant Margin Expansion
Read More
Trendline
Pulse Biosciences Reports Q1 2026 Financial Results and Strategic Developments in Cardiac Catheter Technology
Pulse Biosciences Reports Q1 2026 Financial Results and Strategic Developments in Cardiac Catheter Technology
Read More
Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
